Stockreport

Foghorn Therapeutics appoints Kristian Humer as chief financial officer [Seeking Alpha]

Viridian Therapeutics, Inc.  (VRDN) 
PDF Humer joins Foghorn with over 14 years of diversified financial strategy and business development experience in the life science industry and more than 20 years of expe [Read more]